According to previous Phase II clinical trials, onapristone is shown to exhibit anti-tumour activity in patients with breast cancer. The pre-clinical testing has demonstrated that onapristone had blocked
The deal, which is the first broad research collaboration between PatientsLikeMe and a pharmaceutical company, offers PatientsLikeMe the opportunity to expand its patient network in oncology. PatientsLikeMe co-founder
Pursuant to the terms of the agreement, Shape Pharma will be acquired by TetraLogic Pharma for an upfront cash payment of $13m. TetraLogic will also be responsible for
According to the company, data submitted in the NDAs support the use of DCV+ASV in patients with genotype 1b hepatitis C (HCV). The company also seeks approval for
According to the company, PALOMA-1 met its primary endpoint by prolonging progression-free survival (PFS) compared with letrozole alone in post-menopausal women with estrogen receptor positive (ER+), human epidermal
The recent reports have demonstrated PD-L1 to be up-regulated on the surface of tumor cells, implicating this protein as one of the factors that allows tumors to evade
OMS721 targets mannan-binding lectin-associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system. In 2013, the company had announced that the FDA granted
With the three-year agreement, the company now enters into the growing Canadian OTC drug market, which was valued at more than $3.1bn in 2012. Jestaw has over 14
The boards of directors of Sun Pharma, Ranbaxy, and Daiichi Sankyo, which is Ranbaxy’s controlling shareholder, have unanimously approved the proposed transaction. Ranbaxy’s board and Sun Pharma’s board
Tafluprost, which is indicated for the treatment of glaucoma and ocular hypertension, is trademarked as Zioptan in the US and as Tapros in Japan. Oak recently acquired tafluprost
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.